Objective: To present the cytological features of a very rare and lethal ovarian neoplasm occurring in the young. Study Design: We reviewed the cytological findings as they presented in touch imprints obtained from an ovarian mass sent to our department for frozen section investigation. Results: Smears were highly cellular. The cells were of intermediate size with a moderate amount of microvacuolated, pale, or eosinophilic cytoplasm with indistinct cell borders. The nuclei were of round or oval shape with mild to moderate atypia and indistinct nucleoli. Conclusions: The diagnosis of small cell carcinoma of the ovary can be challenging even histologically. Cytology can be an invaluable adjunct to hematoxylin-eosin sections both pre- or intraoperatively. Although it is a very rare occurrence and cytological results are almost absent in the literature, our case can make cytopathologists more acquainted with the cytological features of this rare tumor entity especially in association with a characteristic clinical profile. Furthermore, the cytological features of small cell carcinoma of the ovary, large cell variant, have only rarely been described in the literature.

Keywords:
Small cell carcinoma, Ovary, Large cell variant, Hypercalcemic type, Cytological features
1.
Dickersin GR, Kline IW, Scully RE: Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases. Cancer 1982;49:188-197.
2.
Powell D, Singer F, Murray T, Minkin C, Potts J: Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med 1973;289:176-191.
3.
Di Vagno G, Melilli GA, Cormio G, Piscitelli D, Ciampolillo A, Resta L, Selvaggi L: Large cell variant of small cell carcinoma of the ovary with hypercalcemia. Arch Gynecol Obstet 2000;264:157-158.
4.
Matias-Guiu X, Prat J, Young RH, Capen CC, Rosol TJ, DeLellis RA: Human parathyroid hormone-related protein (PTHrP) in ovarian small cell carcinomas. Cancer 1994;73:1878-1881.
5.
Chen L, Dinh TA, Haque A: Small cell carcinoma of the ovary with hypercalcemia and ectopic parathyroid hormone production. Arch Pathol Lab Med 2005;129:531-535.
6.
Ulbright TM, Roth LM, Stehman FB, Talerman A, Senekjian EK: Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germ cell origin. Hum Pathol 1987;18:175-184.
7.
Aguirre P, Thor AD, Scully RE: Ovarian small cell carcinoma: histogenetic considerations based on immunohistochemical and other findings. Am J Clin Pathol 1989;92:140-149.
8.
Abrams J, Silverberg SG: The role of intra-operative cytology in the evaluation of gynaecologic disease. Pathol Annu 1989;24:167-187.
9.
Dharan M: Intraoperative cytology of small cell carcinoma of the ovary with hypercalcemia. A case report. Acta Cytol 1993;37:61-66.
10.
Shintaku M, Wada K, Wakasa T, Mise Y: Small cell carcinoma of the ovary of the hypercalcemic type: intraoperative cytological findings of a case. J Jpn Soc Clin Cytol 2015;54:164-169.
11.
Young RH, Oliva E, Scully R: Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 1994;18:1102-1116.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.